¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"axon loss polyneuropathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® axon ÇÑ±Û Ãà»è
¼³¸í   
  ´º·±(½Å°æ¿ø-½Å°æ¼¼Æ÷)ÀÇ ÇѺκÐÀ¸·Î ½Å°æÀÇ Àü±âÀû ½ÅÈ£¸¦ ´Ù¸¥ ½Å°æÀ̳ª ±â°ü¿¡ ÀüÇØÁִ ±ä ±¸Á¶¸¦ À̸£´Â ¸».
  
  Ãà»è
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyneuropathy
    ¿©·¯½Å°æº´(Áõ), ´Ù¹ß½Å°æº´(Áõ)
  • paraneoplastic polyneuropathy
    ½Å»ý¹°µþ¸²¿©·¯½Å°æº´(Áõ), ½Å»ý¹°µþ¸²´Ù¹ß½Å°æº´(Áõ)
  • axon
    ̈ȏ
  • axon blocker
    Ãà»èÂ÷´ÜÁ¦
  • axon hillock
    Ãà»èµÐ´ö
  • axon reaction
    Ãà»è¹ÝÀÀ
  • axon reflex
    Ãà»è¹Ý»ç
  • axon terminal
    Ãà»èÁ¾¸»
  • fusimotor axon
    ¹æÃß¼Ó±Ù(À°)¼¼Æ÷Ãà»è
  • audiometric hearing loss
    û·Â¼Ò½Ç
  • abrasion loss
    ¸¶¸ê·®, ¸¶¸ð·®
  • allowable blood loss
    Çã¿ë½ÇÇ÷·®, Çã¿ëÇ÷¾×»ó½Ç·®
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • conductive hearing loss
    ÀüÀ½³­Ã», Àüµµ³­Ã»
  • congenital hereditary hearing loss
    ¼±ÃµÀ¯Àü³­Ã»
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • axon
    ̈ȏ
  • axon hillock
    Ãà»èµÐ´ö
  • polyneuropathy neuropathy
    ½Å»ý¹°µþ¸²¿©·¯½Å°æº´Áõ, ½Å»ý¹°µþ¸²´Ù¹ß½Å°æº´Áõ
  • polyneuropathy
    ¿©·¯½Å°æº´Áõ, ´Ù¹ß½Å°æº´Áõ
  • paraneoplastic polyneuropathy
    ½Å»ý¹°µþ¸²¿©·¯½Å°æº´Áõ, Á¾¾çµþ¸²´Ù¹ß½Å°æº´Áõ
  • loss
    »ó½Ç
  • abrasion loss
    ¸¶¸ê·®, ¸¶¸ð·®
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • loss of short-term variability
    ´Ü±âº¯µ¿¼Ò½Ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • polyneuropathy
    ´Ù¹ß½Å°æº´Áõ, ¿©·¯½Å°æº´Áõ
  • axon
    ̈ȏ
  • axon blocker
    Ãà»èÂ÷´ÜÁ¦
  • axon hillock
    Ãà»èµÐ´ö
  • axon reaction
    Ãà»è¹ÝÀÀ
  • axon reflex
    Ãà»è¹Ý»ç
  • fusimotor axon
    ¹æÃß¼Ó±ÙÀ°¼¼Æ÷Ãà»è
  • abrasion loss
    ¸¶¸ê·®, ¸¶¸ð·®
  • allowable blood loss
    Çã¿ë½ÇÇ÷·®
  • audiometric hearing loss
    û·Â¼Ò½Ç
  • blood loss
    ½ÇÇ÷, Ç÷¾×»ó½Ç
  • cell loss
    ¼¼Æ÷¼Ò½Ç
  • central hearing loss
    ÁßÃßû·Â¼Ò½Ç, ÁßÃß³­Ã»
  • condensed milk conductive hearing loss
    ³óÃà¿ìÀ¯ÀüµµÃ»°¢¼Ò½Ç
  • conductive hearing loss
    Àüµµ³­Ã»
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • recurrent axon collateral
    ¹ÝȸÃà»èÃøÁö(ÚãüÞõîßãö°ò«).
  • recurrent axon collateral
    ¹Ýȸ Ãà»è ÃøÁö(ÚãüÞõîßãö°ò«).
  • arsenical polyneuropathy
    ºñ¼Ò(¼º) ´Ù¹ß¼º ½Å°æº´Áõ.
  • polyneuropathy
    ´Ù¹ß½Å°æº´Áõ.
  • polyneuropathy
    ´Ù¹ß½Å°æº´Áõ(ÒýÛ¡ãêÌèÜ»ñø)
  • porphyric polyneuropathy
    Æ÷¸£ÇǸ°¼º ´Ù¹ß½Å°æº´Áõ.
  • porphyric polyneuropathy
    Æ÷¸£ÇǸ°¼º ´Ù¹ß½Å°æº´Áõ(¡­àõ ÒýÛ¡ãêÌèÜ»ñø)
  • relapsing polyneuropathy
    Àç¹ß¼º ´Ù¹ß½Å°æº´Áõ(¡­ÒýÛ¡ãêÌèÜ»ñø).
  • relapsing polyneuropathy
    Àç¹ß¼º ´Ù¹ß½Å°æº´Áõ(¡­ÒýÛ¡ãêÌèÜ»ñø)
  • Heat loss
    ¿­¼Õ½Ç(æðáßã÷)
  • NIHL [=noise induced hearing loss]
    ¼ÒÀ½¼º ³­Ã»
  • abrasion loss
    ¸¶¸ê·®(¸¶¸ê¾ç).
  • functional hearing loss
    ±â´É(¼º) ³­Ã»
  • hearing loss
    °¨°¢½Å°æ(¼º) ³­Ã»
  • hearing loss
    ³­Ã», û·Â¼Ò½Ç, û·ÂÀå¾Ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • axon
    Ãà»è(õîÞþ)
  • axon
    ̈ȏ
  • axon hillock
    Ãà»è(õîÞþ), µÐ´ö
  • axon hillock
    Ãà»èµÐ´ö
  • axon neurite
    ̈ȏ
  • axon olfactory nerve fiber
    Ãà»è Èİ¢½Å°æ¼¶À¯
  • axon potential
    ̈ȏ˟ˤ
  • axon reaction =axonal r.
    Ãà»è¹ÝÀÀ
  • axon reflex
    Ãà»è¹Ý»ç
  • recurrent axon collateral
    ¹Ýȸ Ãà»è ÃøÁö(ÚãüÞõîßãö°ò«).
  • recurrent axon collateral
    ¹ÝȸÃà»èÃøÁö(ÚãüÞõîßãö°ò«).
  • alcoholic polyneuropathy
    ¾ËÄڿüº ´Ù¹ß (¼º)½Å°æº´Áõ(ÒýÛ¡àõãêÌèÜ»ñø).
  • arsenical polyneuropathy
    ºñ¼Ò(¼º) ´Ù¹ß¼º ½Å°æº´Áõ.
  • diphtheritic polyneuropathy
    µðÇÁÅ׸®¾Æ¼º ´Ù¹ß½Å°æº´Áõ(¡­ÒýÛ¡ãêÌèÜ»ñø).
  • familial amyloid polyneuropathy
    °¡Á·¼º ¾Æ¹Ð·ÎÀÌµå ´Ù¹ß½Å°æº´Áõ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Axon [Neurite]
    ̈ȏ
    [¿¾ ¿ë¾î] Ãà»è¼Ò±¸
  • Axon [Olfactory nerve fiber]
    Ãà»è [Èİ¢½Å°æ¼¶À¯]
    [¿¾ ¿ë¾î] Ãà»è
  • Axon hillock
    Ãà»èµÐ´ö
    [¿¾ ¿ë¾î] Ãà»è¼Ò±¸
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • axon
    Ãà»è(õîÞþ)
  • coincidence loss
    µ¿½Ã¼Õ½Ç(ÔÒãÁáßã÷)
  • counting loss
    "°èÃø ¼Õ½Ç(ͪö´áßã÷), (ÔÒ) coincidence loss"
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • axon
    ̈ȏ
  • central hearing loss
    ÁßÃß¼º û·Â»ó½Ç, ÁßÃß¼º ³­Ã»
  • energy loss
    ¿¡³ÊÁö¼Õ½Ç
  • hearing loss
    û°¢¼Õ½Ç
  • high velocity signal loss
    °í¼Óµµ½ÅÈ£¼Ò½Ç
  • sensorineural hearing loss
    °¨°¢½Å°æ¼º³­Ã»
  • signal loss
    ½ÅÈ£¼Ò½Ç
  • weight loss
    üÁß°¨¼Ò, °¨·®
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IDA   1) Imino-Diacetic Acid
  2) Iron Deficiency Anemia
   &nb...
DSPN distal sensory polyneuropathy; distal symmetrical polyneuropathy
GnRH Gonadotropin Releasing Hormone  [HP 1898, 2034]
  = LHRH
  = Go...
GAN giant axon neuropathy
MA malignant arrhythmia; management and administration; mandelic acid; masseter; Master of Arts; matern...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
Q-SART Quantitative Sudomotor Axon Reflex Test
MGA medial giant axon
AIDP Acute inflammatory demyelinating polyneuropathy
CIDP Chronic Inflammatory Demyelinating Polyneuropathy
CIP Critical illness polyneuropathy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • familial amyloid polyneuropathy
    °¡Á·¼º ¾Æ¹Ð·ÎÀÌµå ´Ù¹ß ½Å°æº´Áõ
  • polyneuropathy
    ´Ù¹ß¼º ½Å°æ º´º¯, ´Ù¹ß¼º ½Å°æº´Áõ, ´Ù¹ß ½Å°æº´Áõ
    ¿©·¯ °³ÀÇ ½Å°æÀ» ÀÌȯÇÏ´Â ÁúȯÀ¸·Î¼­ º¸Åë ¾çÃø¼ºÀÌ°í ¹Ì¸¸¼ºÀÌ´Ù.
  • afferent axon
    ±¸½É Ãà»è
  • anterolateral quadrant axon
    Àü¿ÜÃø »çºÐÀÇ ÀÏ Ãà»è
  • apposed axon
    ±ÙÁ¢µÈ Ãà»èµ¹±â
  • axon group
    Ãà»è ±º
  • axon reflex
    Ãà»è ¹Ý»ç
    ½Å°æÀÇ ÇÑ °¡Áö¿¡ ÁÖ¾îÁø ÀÚ±ØÀÌ Ãæµ¿À» Çü¼ºÇÏ¿© ±× ½Å°æÀ» µû¶ó ±¸½É¼ºÀ¸·Î ºÐ±âÁ¡±îÁö ÀüÇØÁö°í ¿©±â¼­ºÎÅÍ´Â ´Ù¸¥ °¡Áö¸¦ ÂÑ¾Æ ÁÖÈ¿ ±â°ü¿¡ Àü´ÞµÇ¾î ³»·Á°¡´Â ¹Ý»ç.
  • cell axon terminal
    ¼¼Æ÷ Ãà»è Á¾¸»
  • descending axon
    ÇÏÇà Ãà»è
  • peripheral axon
    ¸»ÃÊ Ãà»è
  • primary afferent axon
    ÀÏÂ÷ ±¸½É¼º Ãà»è
  • regenerating axon
    Àç»ý Ãà»è
  • sensory axon
    °¨°¢ Ãà»è
  • spinoreticular axon
    ô¼ö ¸Á»ó Ãà»è
  • spinothalamic tract axon
    ô¼ö ½Ã»ó·Î Ãà»è
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
axon loss polyneuropathy A type of polyneuropathy in which axon degeneration is the sole/predominant feature; many aetiologies, particularly toxic and metabolic; on nerve conduction studies, affects amplitudes of the responses, but does not cause conduction slowing or block.
Synonym: axonal polyneuropathy.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
axon <cell biology> A long process of a neuron, that carries efferent (outgoing) action potentials from the cell body towards target cells.
Each nerve cell has one axon, which can be over a foot long. A nerve cell communicates with another nerve cell by transmitting signals from the branches at the end of its axon. At the terminal end of the axon, the impulses are transmitted to other nerve cells or to effector organs.
In the peripheral nervous system, the larger (myelinated) axons are surrounded by a myelin sheath formed by concentric layers of plasma membrane of the schwann cell.
In the central nervous system, the function of the schwann cell is supplied by oligodendrocytes (oligodendroglia).
See: dendrite.
(03 Jul 1999)
axon degeneration A type of peripheral nerve fibre response to insult, wherein axon death and subsequent breakdown occurs, with secondary breakdown of the myelin sheath associated; caused by focal injury to peripheral nerve fibres; often referred to as wallerian degeneration.
Synonym: axon degeneration.
(05 Mar 2000)
axon hillock <cell biology> Tapering region between a neuron's cell body and its axon. This region is responsible for summating the graded inputs from the dendrites and producing action potentials if the threshold is exceeded.
(12 Mar 1998)
axon reflex An effect brought about by the passage of the nerve impulses from a sensory ending to the effector organ along divisions of the nerve fibre without traversing a synapse, e.g., as in the vasodilation resulting from stimulation of the skin or the irritation of the conjunctiva; the reaction occurs even when the nerve fibre has been sectioned and thus isolated from the nervous centres.
(05 Mar 2000)
axon terminals The somewhat enlarged, often club-shaped endings by which axons make synaptic contacts with other nerve cells or with effector cells (muscle or gland cells). As isolated, by homogenizing brain or spinal cord, they contain acetylcholine and the related enzymes. Terminals contain neurotransmitters of various kinds, sometimes more than one. These can be demonstrated by chemical analysis and immunocytochemical methods.
See: synapse.
Synonym: axonal terminal boutons, end-feet, neuropodia, pieds terminaux, synaptic boutons, synaptic endings, synaptic terminals, terminal boutons, bouton terminaux.
(05 Mar 2000)
giant axon <biology> Extraordinarily large unmyelinated axons found in invertebrates.
Some, like the squid giant axon, can approach 1 mm diameter. Large axons have high conduction speeds, the giant axons are invariably involved in panic or escape responses and may (e.g. Crayfish) have electrical synapses to further increase speed.
Vertebrate axons with high conduction velocites are much narrower: they are myelinated, allowing saltatory conduction.
(17 Dec 1997)
cervix of the axon The constricted portion of the axon just before the myelin sheath begins.
(05 Mar 2000)
squid giant axon <physiology> Large axons, up to 1mm in diameter, that innervate the mantle of the squid. Because of their large size, many of the pioneering investigations of the mechanisms underlying resting and action potentials in excitable cells were done on these fibres.
(10 Mar 1998)
acute demyelinating polyneuropathy <neurology> A neurologic condition.
Synonym: Guillain-Barre syndrome.
Origin: Gr. Pathos = disease
(27 Sep 1997)
acute inflammatory polyneuropathy <neurology, syndrome> Acute infective polyneuritis that results in a form of peripheral neuropathy with temporary loss of movement and sensation due to inflammation of multiple nerves and loss of myelin.
The exact cause is unknown but has been associated with an abnormal immune response to viral infection, particularly cytomegalovirus infection, in which there is cell-mediated immunity to a component of myelin. The disease may be autoimmune in origin and complete recovery can take up to six months.
Synonym: Guillain-Barre syndrome
(12 Jul 2000)
alcoholic polyneuropathy <neurology> A disorder that occurs secondary to the damage to nerve cells from habitual alcohol abuse.
The effects of alcoholic polyneuropathy may be due in part to the direct toxic effect alcohol has on nervous tissue in combination with specific nutritional deficiencies (for example B1 or thiamin deficiency and B12 deficiency).
Common symptoms include sensory changes, numbness, tingling, muscle weakness, muscle cramps, heat intolerance, impotence, difficulty urinating, swallowing difficulty, speech impairment, diarrhoea and constipation.
Origin: Gr. Pathos = disease
(27 Sep 1997)
arsenical polyneuropathy An axon loss polyneuropathy that results from subacute or chronic arsenic poisoning; almost always preceded by gastrointestinal symptoms; one of the heavy metal neuropathies.
(05 Mar 2000)
axonal polyneuropathy A type of polyneuropathy in which axon degeneration is the sole/predominant feature; many aetiologies, particularly toxic and metabolic; on nerve conduction studies, affects amplitudes of the responses, but does not cause conduction slowing or block.
Synonym: axonal polyneuropathy.
(05 Mar 2000)
buckthorn polyneuropathy Ascending polyneuropathy resulting from ingestion of the fruit of Karwinskia humboldtiana.
(05 Mar 2000)
chronic inflammatory demyelinating polyneuropathy An uncommon, acquired, demyelinating sensorimotor polyneuropathy, clinically characterised by insidious onset, and slow evolution, (either steady progression or stepwise), and chronic course; symmetrical weakness is a predominant symptom, often involving proximal leg muscles, accompanied by paresthesias, but not pain; CSF examination shows elevated protein, while electrodiagnostic studies reveal evidence of a demyelinating process, primarily conduction slowing rather than block; sometimes responds to prednisone.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • axon
    (½Å°æ ¼¼Æ÷ÀÇ)Ãà»è
  • be at a loss
    ºÒÈ®½ÇÇÑ »óÅ¿¡ ÀÖ´Ù
  • loss
    ºÐ½Ç
  • consequential loss insurance
    °£Á¢ ¼ÕÇØ º¸Çè
  • dead loss
    Àü¼Õ
  • friction loss
    ¸¶Âû¼Õ½Ç
  • loss
    ¼Õ½Ç;»ó½Ç;¼ÕÇØ;½ÇÆÐ;ÆÐ¹è;¼Ò¸ð;at a ~ °ï¶õÇÏ¿©;¾î¿ ÁÙ ¸ô¶ó¼­
  • loss leader
    Ư¸Åǰ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á